Nagoya team uses silver nanoparticles to make longer DNA sticky ends

Researchers in Japan have reported a way to cut DNA precisely with silver nanoparticles and leave sticky ends (single-stranded overhangs) longer than conventional ones, ScienceDaily reported in August 2026. Fragments joined up to 5 times as efficiently as with the conventional method (the Nagoya University release gives a range of 2 to 5 times), which could make it simpler to build large DNA molecules. A Nagoya University release identifies the team as researchers at Nagoya University and Gifu University and says the work was published in Nucleic Acids Research.

It looks like a small result, but it sits upstream of nucleic acid drug and vector manufacturing. When DNA fragments are joined, single-stranded overhangs at their ends pair with complementary sequences on their own, and that temporary pairing gives the joining enzyme a foothold. Restriction enzymes usually leave overhangs of only a few bases, which works when few pieces are being joined. Short overhangs pair weakly, so joining efficiency stays low even when the temperature is lowered. Few bases also allow few distinct combinations, which makes it hard to join many fragments at once in a set order. And when several overhangs share a sequence, fragments join in the wrong order. Longer overhangs pair more stably and allow more sequence variety, so assembling many fragments in one step, in the right order, becomes realistic.

Cutting with particles instead of enzymes changes some manufacturing questions. A restriction enzyme cuts only at its recognition sequence, which may not sit where it is needed. The enzyme is also a protein raw material, with lot-to-lot variation, a removal step after the reaction and, for some products, few suppliers. Inorganic particles avoid sequence constraints and enzyme-derived impurities. They bring their own issues. Silver becomes a residue, which in a drug context falls under elemental impurity control (ICH Q3D), and the dispersion state of the particles can affect reproducibility.

Assembling long DNA is a bottleneck in several areas: building plasmid DNA vectors, making DNA templates for mRNA in vitro transcription, enzymatic production of linear and doggybone DNA without bacteria, and gene therapy vectors with long payloads. Higher assembly yield shortens upstream work. The method is a research result, not a product. The lead researcher says it has yet to be confirmed that several fragments can be joined at once, the case that matters for large constructs, and the conditions behind the fivefold figure need checking against the paper.